Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN of Neoadjuvant BOT/BAL in MSS Colon Cancer
NCCN Breast Cancer Version 4.2026: Metastatic Treatment Moves Further Toward Biomarker-Driven Sequencing
The Future of Oncology is Ensuring the Discoveries Reach Every Patient - CancerWorld
Risvutatug Rezetecan Meets Overall Survival Endpoint in Phase III SCLC Trial in China
Ophira Ginsburg: Why ASCO Africa Was a Standout Meeting for Cancer Equity
10 Must-Read Posts In GU Oncology This Week
San Diego's Largest Community-Powered Cancer Research Fundraiser Returns: Curebound Cancer Challenge to Accelerate Cures
Anthony Letai: New Research Classifies More Than 6,500 BRCA2 Variants to Improve Risk Assessment
